Seven-year OurCrowd veteran had served as acting CEO since mid-2025, when founder Jon Medved stepped back for medical reasons; his formal appointment follows an operational overhaul and reported $2.4 billion sale of portfolio company BioCatch to Visa

Seven-year company veteran formally takes helm after founder Jon Medved stepped back from day-to-day management last year.

Seven-year OurCrowd veteran had served as acting CEO since mid-2025, when founder Jon Medved stepped back for medical reasons; his formal appointment follows an operational…